If BETONMACE meets its primary endpoint and some secondary indications and Apabetalone gets final FDA  and EMA approval then the winning BP who ever gets will most likely hiring a communications/ PR firm that deals in Drug marketing to make an easy to understand explanation in easy layman terms for what the drug actually does, All this science jargon makes it very difficult to explain to someone what Apabetalone actually does . Cutting edge edge / first in class science is never easy to explain let alone epigenetics